197 related articles for article (PubMed ID: 31885819)
1. LOX-1, the Common Therapeutic Target in Hypercholesterolemia: A New Perspective of Antiatherosclerotic Action of Aegeline.
Singh A; Srinivasan AK; Chakrapani LN; Kalaiselvi P
Oxid Med Cell Longev; 2019; 2019():8285730. PubMed ID: 31885819
[TBL] [Abstract][Full Text] [Related]
2. Atorvastatin reduces platelet-oxidized-LDL receptor expression in hypercholesterolaemic patients.
Puccetti L; Sawamura T; Pasqui AL; Pastorelli M; Auteri A; Bruni F
Eur J Clin Invest; 2005 Jan; 35(1):47-51. PubMed ID: 15638819
[TBL] [Abstract][Full Text] [Related]
3. The LOX-1 receptor ectopically expressed in the liver alleviates atherosclerosis by clearing Ox-LDL from the circulation.
Wang Z; Chen J; Zeng Z; Zhang Q; Du G; Guo X; Wei Y
Mol Med; 2022 Mar; 28(1):26. PubMed ID: 35236285
[TBL] [Abstract][Full Text] [Related]
4. Different effect of statins on platelet oxidized-LDL receptor (CD36 and LOX-1) expression in hypercholesterolemic subjects.
Bruni F; Pasqui AL; Pastorelli M; Bova G; Cercignani M; Palazzuoli A; Sawamura T; Gioffre WR; Auteri A; Puccetti L
Clin Appl Thromb Hemost; 2005 Oct; 11(4):417-28. PubMed ID: 16244767
[TBL] [Abstract][Full Text] [Related]
5. [Effect and mechanism of PCSK9 on lectin-like oxidized low-density lipoprotein receptor-1 mediated oxidized low-density lipoprotein uptake by THP-1 derived macrophages].
Bao HL; Liao FJ; Fang L; Zhong F; Liu W; Li JQ
Zhonghua Xin Xue Guan Bing Za Zhi; 2019 May; 47(5):367-373. PubMed ID: 31142080
[No Abstract] [Full Text] [Related]
6. Role of oxidized LDL and lectin-like oxidized LDL receptor-1 in cerebral vasospasm after subarachnoid hemorrhage.
Matsuda N; Ohkuma H; Naraoka M; Munakata A; Shimamura N; Asano K
J Neurosurg; 2014 Sep; 121(3):621-30. PubMed ID: 24949677
[TBL] [Abstract][Full Text] [Related]
7. Hexarelin attenuates atherosclerosis via inhibiting LOX-1-NF-κB signaling pathway-mediated macrophage ox-LDL uptake in ApoE
Cheng XL; Ding F; Wang DP; Zhou L; Cao JM
Peptides; 2019 Nov; 121():170122. PubMed ID: 31386895
[TBL] [Abstract][Full Text] [Related]
8. Association of angiotensin II receptor 1 and lectin-like oxidized low-density lipoprotein receptor-1 mediates the cardiac hypertrophy induced by oxidized low-density lipoprotein.
Zhao Y; Li Y; Ning X; Chen K; Zhang S
Biochem Biophys Res Commun; 2017 Aug; 490(1):55-61. PubMed ID: 28595908
[TBL] [Abstract][Full Text] [Related]
9. 3'UTR/T polymorphism of lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1) is associated with modified anti-platelet activity of atorvastatin in hypercholesterolemic subjects.
Puccetti L; Pasqui AL; Pastorelli M; Ciani F; Palazzuoli A; Gioffrè W; Auteri A; Bruni F
Atherosclerosis; 2005 Dec; 183(2):322-8. PubMed ID: 16285995
[TBL] [Abstract][Full Text] [Related]
10. Electronegative low-density lipoprotein increases C-reactive protein expression in vascular endothelial cells through the LOX-1 receptor.
Chu CS; Wang YC; Lu LS; Walton B; Yilmaz HR; Huang RY; Sawamura T; Dixon RA; Lai WT; Chen CH; Lu J
PLoS One; 2013; 8(8):e70533. PubMed ID: 23950953
[TBL] [Abstract][Full Text] [Related]
11. [Effects of Gualou Xiebai Banxia decoction on blood lipid content, oxidative stress and ox-LDL/Lox-1 pathway in ApoE-/- mice].
Guo JE; Mi SB; Yan XC; Xin SY; Gao F; Liang GH; Li JH
Zhongguo Zhong Yao Za Zhi; 2017 Feb; 42(4):752-757. PubMed ID: 28959848
[TBL] [Abstract][Full Text] [Related]
12. Exploring the druggability of oxidized low-density lipoprotein (ox-LDL) receptor, LOX-1, a proatherogenic drug target involved in atherosclerosis.
Tomar A; Sahoo S; Aathi M; Kuila S; Khan MA; Ravi GRR; Jeyaraman J; Mehta JL; Varughese KI; Arockiasamy A
Biochem Biophys Res Commun; 2022 Oct; 623():59-65. PubMed ID: 35872543
[TBL] [Abstract][Full Text] [Related]
13. [Early intervention on atherosclerosis by fluvastatin and lectin-like oxidized low-density lipoprotein receptor-1 expression in atherosclerotic arteries in immature rabbits].
Yu YH; Wang Y; Chen Y; Liu ZZ; Sun SZ; Meng XH
Zhonghua Er Ke Za Zhi; 2005 Oct; 43(10):762-6. PubMed ID: 16255856
[TBL] [Abstract][Full Text] [Related]
14. Oxidized LDL, LOX-1 and atherosclerosis.
Mitra S; Goyal T; Mehta JL
Cardiovasc Drugs Ther; 2011 Oct; 25(5):419-29. PubMed ID: 21947818
[TBL] [Abstract][Full Text] [Related]
15. The hydrogen sulfide donor, GYY4137, exhibits anti-atherosclerotic activity in high fat fed apolipoprotein E(-/-) mice.
Liu Z; Han Y; Li L; Lu H; Meng G; Li X; Shirhan M; Peh MT; Xie L; Zhou S; Wang X; Chen Q; Dai W; Tan CH; Pan S; Moore PK; Ji Y
Br J Pharmacol; 2013 Aug; 169(8):1795-809. PubMed ID: 23713790
[TBL] [Abstract][Full Text] [Related]
16. Modulation of oxidized-LDL receptor-1 (LOX1) contributes to the antiatherosclerosis effect of oleanolic acid.
Jiang Q; Wang D; Han Y; Han Z; Zhong W; Wang C
Int J Biochem Cell Biol; 2015 Dec; 69():142-52. PubMed ID: 26510581
[TBL] [Abstract][Full Text] [Related]
17. Inhibitory effects of Dioscin on atherosclerosis and foam cell formation in hyperlipidemia rats.
Wang P; He LY; Shen GD; Li RL; Yang JL
Inflammopharmacology; 2017 Dec; 25(6):633-642. PubMed ID: 28365854
[TBL] [Abstract][Full Text] [Related]
18. Protamine may have anti-atherogenic potential by inhibiting the binding of oxidized-low density lipoprotein to LOX-1.
Takemura Y; Okamoto M; Hasegawa M; Hatanaka K; Kubota S
Biosci Biotechnol Biochem; 2019 Jun; 83(6):1094-1101. PubMed ID: 30871430
[TBL] [Abstract][Full Text] [Related]
19. Loxin Reduced the Inflammatory Response in the Liver and the Aortic Fatty Streak Formation in Mice Fed with a High-Fat Diet.
Reyes C; Nova-Lamperti E; Duran-Sandoval D; Rojas D; Gajardo J; Guzman-Gutierrez E; Bustos-Ruiz C; Ormazábal V; Zúñiga FA; Escudero C; Aguayo C
Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35806336
[TBL] [Abstract][Full Text] [Related]
20. [Relationship of ox-LDL/LOX-1 and vascular endothelial dysfunction of diet-induced obese immature rats and nicotinic acid's intervention outcomes].
Niu N; Sun SZ; Han B; Wang Y
Zhonghua Yi Xue Za Zhi; 2013 Nov; 93(42):3388-93. PubMed ID: 24418038
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
